Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Stomach Neoplasms × spartalizumab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Nasopharangeal Cancer 1 Myelodysplastic Syndromes 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Kidney Diseases 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Advanced Malignant Tumors 1 Advanced Malignant Solid Neoplasm 1

Interventions

Oxaliplatin 27 pembrolizumab 22 Fluorouracil 19 Capecitabine 17 Leucovorin 14 Nivolumab 13 Trastuzumab 10 Paclitaxel 7 trastuzumab deruxtecan 6 Specimen Handling 6 S 1 (combination) 6 Irinotecan 6 Docetaxel 6 Cisplatin 6 durvalumab 5 Drug Therapy 5 Bevacizumab 5 zolbetuximab 4 zimberelimab 4 atezolizumab 4 apatinib 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Carboplatin 4 Biopsy 4 zanidatamab 3 olaparib 3 fludarabine 3 avelumab 3 XELOX 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06468280 2026-01-21

ROSETTE

Shanghai Zhongshan Hospital

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡